Q3 2021 Holdings
Filed 2021-11-15 | 3 holdings | $5.3M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2023-11-08) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| United Therapeutics Corp del(UTHR)A | COM | 91307C102 | $82.0M | 444,471 | 5.7% |
| Ascendis Pharma A/S(ASND)A | SPONSORED ADR | 04351P101 | $71.0M | 445,203 | 4.9% |
| Community Health SYS Inc New(CYH)A | COM | 203668108 | $70.1M | 5,988,163 | 4.9% |
| Horizon Therapeutics PUB LA | SHS | G46188101 | $69.5M | 634,670 | 4.8% |
| Acceleron Pharma Inc(XLRN)A | COM | 00434H108 | $60.1M | 349,494 | 4.2% |
| Amarin Corp PLCA | SPONS ADR NEW | 023111206 | $59.2M | 11,604,990 | 4.1% |
| Glaxosmithkline PLCCallA | SPONSORED ADR | 37733W105 | $57.5M | 1,503,700 | 4.0% |
| Astrazeneca PLC(AZN)A | SPONSORED ADR | 046353108 | $53.5M | 890,808 | 3.7% |
| Avantor Inc(AVTR)A | COM | 05352A100 | $52.8M | 1,292,014 | 3.7% |
| ARK ETF TR(ARKG)A | GENOMIC REV ETF | 00214Q302 | $51.5M | 689,501 | 3.6% |
| Danaher Corporation(DHR)A | COM | 235851102 | $45.1M | 147,938 | 3.1% |
| Spdr S&P 500 ETF TR(SPY)PutA | TR UNIT | 78462F103 | $42.9M | 100,000 | 3.0% |
| Amneal Pharmaceuticals Inc(AMRX)A | COM STK CL A | 03168L105 | $36.6M | 6,849,834 | 2.5% |
| Laboratory Corp Amer HldgsA | COM NEW | 50540R409 | $36.1M | 128,311 | 2.5% |
| Teva Pharmaceutical Inds LTD(TEVA)A | SPONSORED ADS | 881624209 | $34.6M | 3,554,804 | 2.4% |
| Envista Holdings Corporation(NVST)A | COM | 29415F104 | $33.9M | 810,881 | 2.4% |
| Mckesson Corp(MCK)A | COM | 58155Q103 | $32.3M | 161,708 | 2.2% |
| Vertex Pharmaceuticals Inc(VRTX)CallA | COM | 92532F100 | $31.4M | 173,300 | 2.2% |
| Bristol-Myers Squibb Co(BMY)A | COM | 110122108 | $27.8M | 464,801 | 1.9% |
| Catalent Inc(CTLTEUR)A | COM | 148806102 | $24.5M | 184,299 | 1.7% |
| Icon PLC(ICLR)A | SHS | G4705A100 | $18.8M | 71,911 | 1.3% |
| Masimo Corp(MASI)A | COM | 574795100 | $18.1M | 67,000 | 1.3% |
| Ortho Clinical Diagnostics HA | ORD SHS | G6829J107 | $16.9M | 914,986 | 1.2% |
| R1 RCM IncA | COM | 749397105 | $16.8M | 764,780 | 1.2% |
| Maravai Lifesciences Hldgs I(MRVI)A | COM CL A | 56600D107 | $16.1M | 327,810 | 1.1% |
| Astrazeneca PLC(AZN)CallA | SPONSORED ADR | 046353108 | $15.6M | 260,300 | 1.1% |
| Fate Therapeutics Inc(FATE)A | COM | 31189P102 | $15.5M | 260,895 | 1.1% |
| Glaxosmithkline PLCA | SPONSORED ADR | 37733W105 | $15.4M | 401,654 | 1.1% |
| Ionis Pharmaceuticals Inc(IONS)A | COM | 462222100 | $15.1M | 450,501 | 1.0% |
| Community Health SYS Inc New(CYH)CallA | COM | 203668108 | $12.6M | 1,077,200 | 0.9% |
| Guardant Health Inc(GH)A | COM | 40131M109 | $12.5M | 100,361 | 0.9% |
| Natera Inc(NTRA)A | COM | 632307104 | $12.5M | 112,189 | 0.9% |
| Sanofi(SNY)A | SPONSORED ADR | 80105N105 | $12.5M | 259,128 | 0.9% |
| Anthem Inc(ELV)A | COM | 036752103 | $11.8M | 31,628 | 0.8% |
| Zogenix IncA | COM NEW | 98978L204 | $11.8M | 774,591 | 0.8% |
| Taro Pharmaceutical Inds LTDA | SHS | M8737E108 | $11.4M | 179,366 | 0.8% |
| Alnylam Pharmaceuticals Inc(ALNY)A | COM | 02043Q107 | $11.2M | 59,233 | 0.8% |
| Exelixis Inc(EXEL)A | COM | 30161Q104 | $10.9M | 516,307 | 0.8% |
| Magellan Health IncA | COM NEW | 559079207 | $9.9M | 104,700 | 0.7% |
| Humana Inc(HUM)A | COM | 444859102 | $9.4M | 24,083 | 0.7% |
| Teva Pharmaceutical Inds LTD(TEVA)CallA | SPONSORED ADS | 881624209 | $9.4M | 962,400 | 0.7% |
| HCA Healthcare Inc(HCA)A | COM | 40412C101 | $9.3M | 38,366 | 0.6% |
| Centene Corp del(CNC)A | COM | 15135B101 | $8.8M | 141,107 | 0.6% |
| Intra-Cellular Therapies Inc(ITCIEUR)A | COM | 46116X101 | $8.6M | 230,744 | 0.6% |
| Perkinelmer Inc(RVTY)A | COM | 714046109 | $8.2M | 47,081 | 0.6% |
| Nanostring Technologies Inc(NSTGEUR)A | COM | 63009R109 | $8.1M | 168,668 | 0.6% |
| Horizon Therapeutics PUB LCallA | SHS | G46188101 | $7.7M | 70,000 | 0.5% |
| Healthequity Inc(HQY)A | COM | 42226A107 | $7.4M | 114,378 | 0.5% |
| Qiagen NV(QGEN)A | SHS NEW | N72482123 | $7.4M | 143,109 | 0.5% |
| Irhythm Technologies Inc(IRTC)A | COM | 450056106 | $6.7M | 113,854 | 0.5% |